Svenja Bolz

Svenja Bolz is a Medical Advisor at Ethypharm, specializing in CNS (addiction, pain, epilepsy) and cardiology since July 2024, with responsibilities in medical advisory, compliance, and relationship management. Prior to this role, Svenja served as a Postdoctoral Researcher and Associate Researcher at Leibniz-Forschungsinstitut für Molekulare Pharmakologie from July 2018 to June 2024, focusing on mechanisms for preservation and regeneration in the hippocampus through advanced microscopy techniques. Earlier experience includes research positions at the University of Melbourne, Max Delbrück Center, Washington University in St. Louis, and Charité, with a strong emphasis on neurodegenerative diseases and protein studies. Svenja holds a Doctor of Science from Freie Universität Berlin and a Master of Science in Biochemistry and Molecular Biology from the University of Potsdam.